ArticleJournal of arrhythmia2025

Challenges to the Long-Term Safety Claims of Extremely Low-Dose Amiodarone: Pulmonary, Thyroid, Hepatic, and Statistical Concerns.

Malik Abdul Rehman Rasheed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.